S&P Equity Research reiterates a 'Buy' rating on Vertex Pharma (Nasdaq: VRTX).

S&P analyst, S. Silver, says, "The shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE